The NIH has created the NIH StrokeNet to conduct small and large clinical trials and research studies to advance acute stroke treatment, stroke prevention, and recovery and rehabilitation following a stroke. This network of 25 regional centers across the U.S., which involves more than 200 hospitals, is designed to serve as the infrastructure and pipeline for exciting new potential treatments for patients with stroke and those at risk for stroke. In addition, NIH StrokeNet will provide an educational platform for stroke physicians and clinical trial coordinators.
In September 2013, the National Institutes of Health funded the stroke trials network, NIH StrokeNet. The StrokeNet infrastructure consists of 25 regional coordinating centers across the US, a national coordinating center at the University of Cincinnati, and a national data management center (Medical University of South Carolina). The primary goal of this network is to maximize efficiencies to develop, promote and conduct high-quality, multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery.
Friday, April 21, 2017
Hilton Garden Inn • Pittsburgh / Southpointe
Sponsored by University of Pittsburgh School of Medicine,
Center for Continuing Education in the Health Sciences, and
Stroke Institute, Department of Neurology
Los Angeles, California
Soon you will receive an invitation with the brochure containing registration information.
Meeting Presidents: John H. Zhang, MD, PhD
Robert Martin, MD
Warren Boling, MD
Loma Linda University, California
ABSTRACTS SUBMISSION OPENS OCTOBER 29, 2016
3712 participants, 259 speakers, 14 best poster award winners, 5 young investigators award winners, 56 sessions, 11 teaching courses, 5 workshops, 1027 poster presentation, 14 poster walks
It’s been 4 months since ESOC 2016 in Barcelona, and preparations for ESOC 2017 in Prague are already well underway.
ESOC 2016 gathered top leaders, researchers, and professionals from the field of stroke management and care. Participants witnessed amazing clinical trial presentations, innovative e-poster sessions, and great hands-on workshops.
The Johns Hopkins University will be hosting the 6th World Intracranial Hemorrhage Conference (WICH 2017) on May 1-3, 2017 in Baltimore Maryland. The conference will feature highly respected speakers who will share, discuss, debate and dissect significant new developments and scientific advancements that will impact the future of intracranial hemorrhage. The planned program will provide learning opportunities for students, medical specialists and clinicians from all fields of endeavor, as well as world-class content for researchers and industry supporters.
Small businesses may apply for cooperative agreement grants: StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01) (PAR-14-220) OR through our Small Business program: StrokeNet Small Business Innovation in Clinical Trials (U44).
Industry may apply for expedited access to StrokeNet expertise and infrastructure through the StrokeNet Infrastructure Resource Access (X01) under a cost-sharing arrangement and Cooperative Research and Development Agreement (CRADA) with NINDS.
Grants For NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)
previous daynext daytoday
NIH StrokeNet Education “Pathophysiological Links between Migraine and Stroke”; Presented by Cenk Ayata, MD, Harvard Medical School, Massachusetts General Hospital NIH StrokeNet Education “Pathophysiological Links between Migraine and Stroke”; Presented by Cenk Ayata, MD, Harvard Medical School, Massachusetts General HospitalNIH StrokeNet Education “Pathophysiological Links between Migraine and Stroke.
Treatments for acute stroke include IV t-PA, stroke centers, stroke units, endovascular thrombectomy devices for selected patients, nimodipine for subarachnoid hemorrhage, and aneurysm coiling and clipping for ruptured aneurysms. Intracerebral hemorrhage has proven to be the most challenging for effective treatments; however recent research has shown promise
Despite the advances made in acute stroke care, stroke remains the leading cause of adult disability in Americans. World-wide there is an estimated 50 million stroke survivors coping with significant physical, cognitive and emotional deficits. The field of stroke recovery and restorative neuroscience is still young and provides a rich environment for innovative trials.